LVAD Market Estimated At 30,000, Thoratec Still Awaiting Coverage Decision
This article was originally published in The Gray Sheet
Executive Summary
The potential U.S. market for artificial replacement hearts, assuming a two-year device lifespan, is about 36,000 patients per year, according to Abiomed